We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current TDSGF market cap is 8.2M. The company's latest EPS is CAD -0.0395 and P/E is -3.80.
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Operating Income | -1.05M | -1.31M | -1.26M | -2.11M | -2.82M |
Net Income | -1.07M | -1.24M | -1.07M | -2.11M | -2.82M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Total Assets | 262k | 1.17M | 3.84M | 2.83M | 2.93M |
Total Liabilities | 1.31M | 393k | 154k | 230k | 313k |
Total Equity | -1.05M | 775k | 3.69M | 2.6M | 2.61M |
Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
Operating | -328k | -1.12M | -1.11M | -1.8M | -2.63M |
Investing | N/A | -8k | -9k | -25k | -69k |
Financing | 280k | 2.03M | 3.83M | 876k | 2.68M |
Market Cap | 8.2M |
Price to Earnings Ratio | -3.80 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 4 |
Price to Book Ratio | 4.1 |
Dividend Yield | - |
Shares Outstanding | 71.31M |
Average Volume (1 week) | 15.83k |
Average Volume (1 Month) | 31.17k |
52 Week Change | -49.89% |
52 Week High | 0.24 |
52 Week Low | 0.0761 |
Spread (Intraday) | 0.08 (50.81%) |
Company Name | Telo Genomics Corporation (QB) |
Address |
1200-750 west pender st vancouver, british columbia V6C 2T8 |
Website | https://www.telodx.com |
Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions